QA: 2seventy bio Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001860782_2022_2seventy_bio_Inc.pdf

Logs

warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': 1.0252590914156234, 'aggregate_val': 54522000, 'exp_sum': 26921000, 'exp_to_value': {'remainder_Revenues': 26921000}}

Graph

Absolute values for 0001860782, 2seventy bio Inc.

  xvar xval
0 AssetsCurrent 291,564,000
1 IntangibleAssetsNetIncludingGoodwill 21,948,000
2 PropertyPlantAndEquipmentNet 34,913,000
3 remainder_Assets 411,250,000
4 LiabilitiesCurrent 98,388,000
5 LiabilitiesNoncurrent 300,330,000
6 remainder_Liabilities 1,135,000
7 CostOfGoodsAndServicesSold 2,517,000
8 SellingGeneralAndAdministrativeExpense 93,506,000
9 ResearchAndDevelopmentExpense 261,937,000
10 remainder_Expenses 10,510,000
11 remainder_Revenues 54,522,000
12 remainder_NetIncome 21,735,000
13 remainder_ComprehensiveNetIncome -712,000
  yvar yval
0 Assets 759,675,000
1 Liabilities 399,853,000
2 Expenses 368,470,000
3 Revenues 54,522,000
4 StockholdersEquity 359,822,000
5 NetIncome -292,213,000
6 ComprehensiveNetIncome -292,569,000
7 BaseVar 802,483,500
8 EconomicCapitalRatio 0.563

Edgar->Model Mapping

Feature Distribution

Change over Time